{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T19:23:21Z","timestamp":1770233001806,"version":"3.49.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ctrv.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T20:26:19Z","timestamp":1538857579000},"page":"245-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Cancer cachexia and myopenia \u2013 Update on management strategies and the direction of future research for optimizing body composition in cancer \u2013 A narrative review"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6142-9762","authenticated-orcid":false,"given":"Edward T.","family":"Pring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Malietzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin H.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanos","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2018.10.002_b0005","unstructured":"WHO. Cancer, World health organization. Health Topics; Cancer. http:\/\/www.who.int\/cancer\/en\/ accessed Oct 2018."},{"issue":"1","key":"10.1016\/j.ctrv.2018.10.002_b0010","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/jcb.10601","article-title":"Skeletal muscle metabolism in physiology and in cancer disease","volume":"90","author":"Giordano","year":"2003","journal-title":"J Cell Biochem"},{"issue":"5","key":"10.1016\/j.ctrv.2018.10.002_b0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2018.10.002_b0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ctrv.2018.10.002_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"10.1016\/j.ctrv.2018.10.002_b0030","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1007\/s13277-016-5009-y","article-title":"Body composition of the host influences dendritic cell phenotype in patients treated for colorectal cancer","volume":"37","author":"Malietzis","year":"2016","journal-title":"Tumor Biol"},{"issue":"12","key":"10.1016\/j.ctrv.2018.10.002_b0035","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3390\/nu9121303","article-title":"Aging gut microbiota at the cross-road between nutrition, physical frailty, and sarcopenia: is there a gut-muscle axis?","volume":"9","author":"Ticinesi","year":"2017","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.ctrv.2018.10.002_b0040","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.clnu.2014.03.007","article-title":"Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia","volume":"33","author":"Biolo","year":"2014","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.ctrv.2018.10.002_b0045","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1152\/physiol.00019.2005","article-title":"Molecular pathways leading to cancer cachexia","volume":"20","author":"Tisdale","year":"2005","journal-title":"Physiology"},{"issue":"9","key":"10.1016\/j.ctrv.2018.10.002_b0050","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1080\/13696998.2016.1181640","article-title":"Cachexia among US cancer patients","volume":"19","author":"Arthur","year":"2016","journal-title":"J Med Econ"},{"issue":"1","key":"10.1016\/j.ctrv.2018.10.002_b0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00000658-200101000-00003","article-title":"Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation","volume":"233","author":"Hasselgren","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctrv.2018.10.002_b0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.002_b0065","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jpainsymman.2014.09.008","article-title":"Correlation between the international consensus definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and patient-centered outcomes in advanced non-small cell lung cancer","volume":"49","author":"Le Blanc","year":"2015","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"10.1016\/j.ctrv.2018.10.002_b0070","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/bjs.10075","article-title":"Influence of body composition profile on outcomes following colorectal cancer surgery","volume":"103","author":"Malietzis","year":"2016","journal-title":"Br J Surg"},{"issue":"11","key":"10.1016\/j.ctrv.2018.10.002_b0075","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","article-title":"Body composition as an independent determinant of 5-fluorouracil - based chemotherapy toxicity","volume":"13","author":"Prado","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2018.10.002_b0080","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/annonc\/mdp605","article-title":"Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma","author":"Antoun","year":"2010","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.ctrv.2018.10.002_b0085","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.ctrv.2018.10.002_b0090","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2018.10.002_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186547","article-title":"Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract","volume":"12","author":"Van Vugt","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.002_b0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","article-title":"Cancer cachexia, mechanism and treatment","volume":"7","author":"Aoyagi","year":"2015","journal-title":"World J Gastrointest Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2018.10.002_b0105","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/1097-0142(197406)33:6<1607::AID-CNCR2820330620>3.0.CO;2-V","article-title":"Corticosteroid therapy of preterminal gastrointestinal cancer","volume":"33","author":"Moertel","year":"1974","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.002_b0110","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0959-8049(96)00486-8","article-title":"Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia\/cachexia and emesis by peripheral blood mononuclear cells of cancer patients","volume":"33","author":"Mantovani","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2018.10.002_b0115","doi-asserted-by":"crossref","unstructured":"Ruiz Garcia V, Carbonell Sanchis R, Gonzalvez Perales J. Megestrol acetate for treatment of anorexia-cachexia syndrome (Review) Cochrane Database of Syst Rev 2013;(3).","DOI":"10.1002\/14651858.CD004310.pub3"},{"issue":"18","key":"10.1016\/j.ctrv.2018.10.002_b0120","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1158\/0008-5472.CAN-04-0425","article-title":"Anticachectic effects of formoterol: A drug for potential treatment of muscle wasting","volume":"64","author":"Busquets","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2018.10.002_b0125","first-page":"1269","article-title":"Phase I\/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy","volume":"22","author":"Greig","year":"2014","journal-title":"Support Care Cancer"},{"issue":"10","key":"10.1016\/j.ctrv.2018.10.002_b0130","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1080\/14712598.2016.1208168","article-title":"Novel therapeutic options for cachexia and sarcopenia","volume":"16","author":"Molfino","year":"2016","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"10.1016\/j.ctrv.2018.10.002_b0135","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00018-011-0883-3","article-title":"Androgens and skeletal muscle: Cellular and molecular action mechanisms underlying the anabolic actions","volume":"69","author":"Dubois","year":"2012","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"10.1016\/j.ctrv.2018.10.002_b0140","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1210\/en.2015-1479","article-title":"Enobosarm (GTx-024) modulates adult skeletal muscle mass independently of the androgen receptor in the satellite cell lineage","volume":"156","author":"Dubois","year":"2015","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.002_b0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: A double-blind, randomised controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2018.10.002_b0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2217\/fon.13.273","article-title":"A potential treatment for cachexia","volume":"10","author":"Srinath","year":"2014","journal-title":"Futur Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2018.10.002_b0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11912-016-0522-0","article-title":"Study design and rationale for the phase 3 clinical development program of enobosarm, a selective androgen receptor modulator, for the prevention and treatment of muscle wasting in cancer patients (POWER trials)","volume":"18","author":"Crawford","year":"2016","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"10.1016\/j.ctrv.2018.10.002_b0160","first-page":"726","article-title":"Treatment of cachexia: An overview of recent developments","volume":"184","author":"Von Haehling","year":"2015","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.002_b0165","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2018.10.002_b0170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jphys.2014.10.002","article-title":"The berg balance scale","volume":"61","author":"Downs","year":"2015","journal-title":"J Physiother"},{"key":"10.1016\/j.ctrv.2018.10.002_b0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.exger.2018.08.006","article-title":"The sit-to-stand muscle power test: An easy, inexpensive and portable procedure to assess muscle power in older people","volume":"112","author":"Alcazar","year":"2018","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.ctrv.2018.10.002_b0180","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/annonc\/mdx192","article-title":"ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia","volume":"28","author":"Currow","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2018.10.002_b0185","first-page":"3845","article-title":"Effect of systemic hyperinsulinemia in cancer patients effect of systemic hyperinsulinemia in cancer patients","volume":"52","author":"Heslin","year":"1992","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.002_b0190","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0960-7404(92)90086-Z","article-title":"The effect of insulin on glucose and protein metabolism in the forearm of cancer patients","volume":"1","author":"Newman","year":"1992","journal-title":"Surg Oncol"},{"issue":"9","key":"10.1016\/j.ctrv.2018.10.002_b0195","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1158\/1078-0432.CCR-06-2720","article-title":"Insulin treatment in cancer cachexia: Effects on survival, metabolism, and physical functioning","volume":"13","author":"Lundholm","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ctrv.2018.10.002_b0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0952-3278(93)90017-Q","article-title":"Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory protein","volume":"48","author":"Tisdale","year":"1993","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"3","key":"10.1016\/j.ctrv.2018.10.002_b0205","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0016-5085(92)90021-P","article-title":"Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer","volume":"103","author":"Anti","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctrv.2018.10.002_b0210","article-title":"Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia","volume":"1","author":"Dewey","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ctrv.2018.10.002_b0215","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jpainsymman.2008.06.005","article-title":"Anorexia-cachexia syndrome: a systematic review of the role of dietary polyunsaturated fatty acids in the management of symptoms, survival, and quality of life","volume":"37","author":"Mazzotta","year":"2009","journal-title":"J Pain Symptom Manage"},{"issue":"05","key":"10.1016\/j.ctrv.2018.10.002_b0220","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1017\/S000711450765795X","article-title":"n-3 Fatty acids, cancer and cachexia: a systematic review of the literature","volume":"97","author":"Colomer","year":"2007","journal-title":"Br J Nutr"},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.002_b0225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/0269216312441382","article-title":"Non-steroidal anti-inflammatory drugs for the treatment of cancer cachexia: A systematic review","volume":"27","author":"Reid","year":"2013","journal-title":"Palliat Med"},{"issue":"1","key":"10.1016\/j.ctrv.2018.10.002_b0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/0284186X.2012.724536","article-title":"Non-steroidal anti-inflammatory treatment in cancer cachexia: A systematic literature review","volume":"52","author":"Solheim","year":"2013","journal-title":"Acta Oncol (Madr)"},{"issue":"21","key":"10.1016\/j.ctrv.2018.10.002_b0235","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.2005.05.1847","article-title":"Comparison of orally administered cannabis extract and delta-9- tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannab","volume":"24","author":"Strasser","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2018.10.002_b0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11912-017-0562-0","article-title":"Update on management of cancer-related cachexia","volume":"19","author":"Anderson","year":"2017","journal-title":"Curr Oncol Rep"},{"issue":"17","key":"10.1016\/j.ctrv.2018.10.002_b0245","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1200\/JCO.2010.33.9473","article-title":"Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers","volume":"29","author":"Bekaii-saab","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2018.10.002_b0250","first-page":"106","article-title":"Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor : selumetinib in patients with cholangiocarcinoma","author":"Prado","year":"2012","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2018.10.002_b0255","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbrc.2004.06.129","article-title":"Exercise normalises overexpression of TNF-\u03b1 in knockout mice","volume":"321","author":"Keller","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1016\/j.ctrv.2018.10.002_b0260","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1096\/fj.02-0670fje","article-title":"Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha productions in humans","volume":"17","author":"Starkie","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.ctrv.2018.10.002_b0265","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-012-0096-0","article-title":"Cancer cachexia prevention via physical exercise : molecular mechanisms","author":"Gould","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"28","key":"10.1016\/j.ctrv.2018.10.002_b0270","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1200\/JCO.2006.08.2024","article-title":"Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: A multicenter randomized controlled trial","volume":"25","author":"Courneya","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ctrv.2018.10.002_b0275","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1055-9965.EPI-04-0736","article-title":"Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins safety and efficacy of weight training in recent breast cancer survivors to alter body composition","volume":"14","author":"Schmitz","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.ctrv.2018.10.002_b0280","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1200\/JCO.2007.15.4963","article-title":"Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer","volume":"27","author":"Segal","year":"2008","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ctrv.2018.10.002_b0285","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1249\/01.mss.0000233803.48691.8b","article-title":"Resistance training and reduction of treatment side effects in prostate cancer patients","volume":"38","author":"Galvao","year":"2006","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.ctrv.2018.10.002_b0290","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.pcan.4500991","article-title":"Endocrine and immune responses to resistance training in prostate cancer patients","volume":"11","author":"Galv\u00e3o","year":"2008","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.002_b0295","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ctrv.2008.11.008","article-title":"Is exercise an acceptable and practical therapy for people with or cured of cancer? A systematic review","volume":"35","author":"Maddocks","year":"2009","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"10.1016\/j.ctrv.2018.10.002_b0300","doi-asserted-by":"crossref","first-page":"O267","DOI":"10.1111\/codi.13429","article-title":"The effects of physical prehabilitation in elderly patients undergoing colorectal surgery: a systematic review","volume":"18","author":"Bruns","year":"2016","journal-title":"Color Dis"},{"key":"10.1016\/j.ctrv.2018.10.002_b0305","article-title":"Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease (Review)","volume":"10","author":"Jones","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ctrv.2018.10.002_b0310","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00421-010-1502-y","article-title":"Physiological and methodological considerations for the use of neuromuscular electrical stimulation","volume":"110","author":"Maffiuletti","year":"2010","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.ctrv.2018.10.002_b0315","article-title":"Pescatello L. ACSM\u2019s guidelines for exercise testing and prescription","author":"Thompson","year":"2010","journal-title":"Ed London Lippincott Williams Wilkins"},{"issue":"6","key":"10.1016\/j.ctrv.2018.10.002_b0320","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jpainsymman.2009.05.011","article-title":"Randomized controlled pilot study of neuromuscular electrical stimulation of the quadriceps in patients with non-small cell lung cancer","volume":"38","author":"Maddocks","year":"2009","journal-title":"J Pain Symptom Manage"},{"issue":"12","key":"10.1016\/j.ctrv.2018.10.002_b0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0086059","article-title":"Neuromuscular electrical stimulation of the quadriceps in patients with non-small cell lung cancer receiving palliative chemotherapy: A randomized phase II study","volume":"8","author":"Maddocks","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ctrv.2018.10.002_b0330","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/gut.52.10.1479","article-title":"Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial","volume":"52","author":"Fearon","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.ctrv.2018.10.002_b0335","first-page":"371","article-title":"Oral nutritional interventions in malnourished patients with cancer\u202f: A systematic review and meta-analysis","author":"Baldwin","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.ctrv.2018.10.002_b0340","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN Guideline ESPEN guidelines on nutrition in cancer patients*","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ctrv.2018.10.002_b0345","unstructured":"NIH U.S. National Library of Medicine. Multimodal intervention for cachexia in advanced cancer patients undergoing chemotherapy (MENAC). https:\/\/ClincalTrials.gov\/ct2\/show\/NCT02330926 [Accesed Sept 2018]."},{"key":"10.1016\/j.ctrv.2018.10.002_b0350","unstructured":"NIH U.S. National Library of Medicine. Vitamin D for muscle metabolic function in cancer cachexia [Internet]. NIH U.S. National Library of Medicine ClincalTrials.gov. [cited 2018 Sep 23]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03144128?cond=cachexia&draw=2&rank=24."},{"key":"10.1016\/j.ctrv.2018.10.002_b0355","unstructured":"NIH U.S. National Library of Medicine. Exercise and nutritional rehabilitation in patients with cancer (ENeRgy). https:\/\/ClincalTrials.gov\/ct2\/show\/NCT03316157 [Accessed Sept 2018]."},{"issue":"4","key":"10.1016\/j.ctrv.2018.10.002_b0360","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/SPC.0000000000000300","article-title":"Practical approaches to managing cancer patients with weight loss","volume":"11","author":"Del","year":"2017","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.ctrv.2018.10.002_b0365","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/bmjspcare-2017-001382","article-title":"A multidisciplinary rehabilitation programme for cancer cachexia improves quality of life","author":"Parmar","year":"2017","journal-title":"BMJ Support Palliat Care"},{"issue":"9","key":"10.1016\/j.ctrv.2018.10.002_b0370","first-page":"2669","article-title":"Assessment of computed tomography (CT)-defined muscle and adipose tissue features in relation to short-term outcomes after elective surgery for colorectal","volume":"25","author":"Martin","year":"2018","journal-title":"Cancer: A Multicenter Approach. Ann Surg Oncol"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737218301646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737218301646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T09:21:22Z","timestamp":1759656082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737218301646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":74,"alternative-id":["S0305737218301646"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2018.10.002","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer cachexia and myopenia \u2013 Update on management strategies and the direction of future research for optimizing body composition in cancer \u2013 A narrative review","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}